2C-iBu
外觀
![]() | |
臨床資料 | |
---|---|
其他名稱 | 2,5-Dimethoxy-4-isobutylphenethylamine; 4-Isobutyl-2,5-dimethoxyphenethylamine; 2C-iBu; 2C-IB; ELE-02; ELE02; ELEU02 |
給藥途徑 | Oral; Ophthalmic |
藥物類別 | Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen; Anti-inflammatory drug |
藥物動力學數據 | |
血漿蛋白結合率 | 74% |
作用時間 | 20小時[1] |
識別資訊 | |
| |
CAS號 | 2504100-82-5 ![]() |
PubChem CID | |
化學資訊 | |
化學式 | C14H23NO2 |
摩爾質量 | 237.34 g·mol−1 |
3D模型(JSmol) | |
| |
|
2C-iBu是一種有機化合物,化學式為C14H23NO2,它是一種血清素5-HT2A受體激動劑,其活性與DOx類藥物DOIB、(R)-DOB、(R)-DOI和DOiP相當或更低。[2]
參考文獻
[編輯]- ^ Shulgin A, Manning T, Daley PF (2011). "#60. DOM". The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. pp. 118–129. ISBN 978-0-9630096-3-0. OCLC 709667010. 2c-IB: [...] (15) Synthesis (from 2,5-dimethoxyisobutylbenzene) (Mueller, 2006); although this compound was reported here, a structure-search in Chemical Abstracts does not produce a CAS registry number (16) Threshold activity in humans at 5 mg orally; long duration (about 20 hours; Mueller, 2006). [...] Mueller, M. (2006) Personal communication with A.T. Shulgin.
- ^ WO published 2020210823, Charles D. Nichols; Gerald Billac & David E. Nichols, "Compounds and methods for treating inflammatory disorders", published 15 October 2020